UNCY
Unicycive Therapeutics Inc. Common Stock
$0.638+0.000 (0.000%)
वास्तविक समय मूल्य
मूल्य चार्ट
Loading Chart...
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$0.638
उच्च
$0.638
कम
$0.638
मात्रा
4.18M
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े
संबंधित समाचार
GlobeNewswire
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,
और देखें
Analyst Upgrades
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.
और देखें
GlobeNewswire
Unicycive Therapeutics to Present at Upcoming Investor Conferences
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh
और देखें
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।